Skip to content
Two human factors - awareness of the virus and fatigue - are battling to control the path of Covid-19.
Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery.
A generator-level model suggests that most fossil fuel power plants could complete normal lifespans and still close by 2035.
When one or more coronavirus vaccines receives FDA emergency use authorization, it will launch a major public health and logistics initiative.
Microneedle patches could provide a means for extracting interstitial fluid to study possible new biomarkers.
Entrepreneur and Professor Raghupathy “Siva” Sivakumar has been named Georgia Tech’s inaugural Interim Chief Commercialization Officer.
Machine learning is helping accelerate the development of highly tunable materials known as metal-organic frameworks.
Flexible large-area organic photodiodes can now compete in performance with conventional silicon photodiode technology.
Simulations of microgel suspensions show the surprising behavior of these materials when they are compressed.
Georgia Tech and Pacific Northwest National Laboratory will expand interactions, collaborations and joint scientific output.
Interventions such as shelter-in-place taken to control the SARS-CoV-2 virus can reduce infections and overall deaths.
A team of researchers is now using what they’ve learned about bio-circuits to lay the groundwork for the future of programmable medicine.
Subscribe to our RSS Feeds with your favorite reader.
Sign up to receive our monthly email newsletter.
Sign up for a free subscription to Research Horizons magazine.
Georgia Institute of TechnologyNorth Avenue, Atlanta, GA 30332Phone: 404-894-2000